Athos Capital LTD Takeda Pharmaceutical CO LTD Transaction History

Athos Capital LTD

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 14, 2021	SELL	$16.71 - $19.9 $1.29 Million - $1.53 Million	-77,000 Closed	0 $0
Q4 2020 Feb 11, 2021	BUY	$15.39 - $18.97 $261,630 - $322,490	17,000 Added 28.33%	77,000 $1.4 Million
Q2 2020 Aug 13, 2020	BUY	$14.59 - $19.5 $875,400 - $1.17 Million	60,000 New	60,000 $1.08 Million
Q4 2019 Feb 11, 2020	SELL	$16.88 - $20.83 $458,511 - $565,805	-27,163 Closed	0 $0
Q3 2019 Nov 13, 2019	SELL	$16.15 - $17.99 $1.77 Million - $1.97 Million	-109,629 Reduced 80.14%	27,163 $467,000
Q1 2019 May 14, 2019	BUY	$16.7 - $21.52 $2.28 Million - $2.94 Million	136,792 New	136,792 $2.79 Million

337

73.8M

1.96M

165K

Ticker TAK
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 3,109,050,112
Market Cap $42.2B
Description
Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan, the United States, Europe, Canada, Latin America, Russia, rest of Asia, and internationally. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma derived t...

Get notified when there are updates to the investment portfolio of Athos Capital LTD, based on Form 13F filings with the SEC.

Stay updated on Athos Capital LTD with notifications on news.